Welcome!

Containers Expo Blog Authors: Liz McMillan, Pat Romanski, Yeshim Deniz, Elizabeth White, Zakia Bouachraoui

News Feed Item

PathCentral Announces Sale of Its Diagnostic Laboratory To Ascend Clinical, LLC; Expands Focus on LIS and Professional Network Business Segments

PathCentral, a technology-enabled company dedicated to the success of the pathology community, today announced the sale of its diagnostic laboratory business to Ascend Clinical, LLC, the end-stage renal disease (ESRD) laboratory testing leader for independent dialysis clinics in the U.S.

Ascend has expertise in both diagnostic testing and IT applications and infrastructure. Ascend intends to leverage all the features PathCentral has developed in its APLIS product, as well as continue the intensive focus on new test development to provide seamless lab service to all clients.

With the sale, PathCentral will expand its focus on its cloud-based technology business units, including its Anatomic Pathology Laboratory Information System (APLIS) and the PathCentral Online Professional Network. The network, slated for launch in early 2013, is designed to connect pathologists around the world with subspecialty expert consultants. PathCentral’s expertise in cloud-based solutions and focus on pathology was built on more than 10 years of established web-based product development.

PathCentral’s core IT infrastructure is the backbone of almost every reference laboratory offering remote review of cases via “technical only” testing today. Applying PathCentral’s expertise in cloud-based end-to-end enterprise solutions with the growing field of digital pathology in an integrated professional network is the next phase of PathCentral’s technical evolution.

As part of the sale of the diagnostic lab, Matt Watson, current CEO of PathCentral, will transition to an executive role within Ascend, providing continuity for lab clients. Jaye Connolly has been named Watson’s successor as Chief Executive Officer, effective immediately. Prior, Connolly had served as Chief Financial Officer of PathCentral for more than two years. Before joining PathCentral, Connolly served as President and CEO of A-Life Medical, Inc., the pioneer and leading provider of computer-assisted coding (CAC) products and services for the healthcare industry.

“As a focused technology company, we now can advance our long term vision, which is to enable pathologists around the globe to tap and harness powerful cloud-based solutions, share their findings, and collaborate on an unprecedented level,” Connolly said.

“Ascend brings a wealth of laboratory business knowledge to the table and our acquisition of PathCentral’s laboratory is a natural step for our company,” said Paul Beyer, CEO of Ascend Clinical. “This new addition to our service offering advances our vision of delivering broad spectrum clinical services. With PathCentral’s extensive laboratory offering and tech-only testing options, we gain a highly respected laboratory that gives us access to new diagnostic markets and entry into an entirely new base within the medical community. During the transition, Ascend is committed to minimizing any change in service levels or commitment to quality. Ascend will continue to develop the world class genomics platform PathCentral launched in 2011. The existing scientific staff, which includes some of the nation’s leading experts in clinical genomics and array CGH-based testing, will remain intact.”

About PathCentral

Through its comprehensive suite of products and services, PathCentral provides independent community-based pathologists with the tools they need to increase revenues, improve operating efficiencies, ensure patient safety, and become highly competitive in their local markets. Through a blend of leading edge IT cloud computing technology and global connectivity, PathCentral intends to enable pathologists around the world to grow, thrive and more effectively meet the demands of 21st Century diagnostic medicine. For more information, please visit www.pathcentral.net.

About Ascend Clinical, LLC

Ascend Clinical, LLC is the ESRD testing leader for independent dialysis clinics in the United States. LabCheck™, LabCheck GO mobile™ and Ascend Chart™ deliver the most complete suite of clinical services built for independent dialysis clinics. For more information, please visit www.ascendclinical.com.

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

IoT & Smart Cities Stories
The deluge of IoT sensor data collected from connected devices and the powerful AI required to make that data actionable are giving rise to a hybrid ecosystem in which cloud, on-prem and edge processes become interweaved. Attendees will learn how emerging composable infrastructure solutions deliver the adaptive architecture needed to manage this new data reality. Machine learning algorithms can better anticipate data storms and automate resources to support surges, including fully scalable GPU-c...
Machine learning has taken residence at our cities' cores and now we can finally have "smart cities." Cities are a collection of buildings made to provide the structure and safety necessary for people to function, create and survive. Buildings are a pool of ever-changing performance data from large automated systems such as heating and cooling to the people that live and work within them. Through machine learning, buildings can optimize performance, reduce costs, and improve occupant comfort by ...
The explosion of new web/cloud/IoT-based applications and the data they generate are transforming our world right before our eyes. In this rush to adopt these new technologies, organizations are often ignoring fundamental questions concerning who owns the data and failing to ask for permission to conduct invasive surveillance of their customers. Organizations that are not transparent about how their systems gather data telemetry without offering shared data ownership risk product rejection, regu...
René Bostic is the Technical VP of the IBM Cloud Unit in North America. Enjoying her career with IBM during the modern millennial technological era, she is an expert in cloud computing, DevOps and emerging cloud technologies such as Blockchain. Her strengths and core competencies include a proven record of accomplishments in consensus building at all levels to assess, plan, and implement enterprise and cloud computing solutions. René is a member of the Society of Women Engineers (SWE) and a m...
Poor data quality and analytics drive down business value. In fact, Gartner estimated that the average financial impact of poor data quality on organizations is $9.7 million per year. But bad data is much more than a cost center. By eroding trust in information, analytics and the business decisions based on these, it is a serious impediment to digital transformation.
Digital Transformation: Preparing Cloud & IoT Security for the Age of Artificial Intelligence. As automation and artificial intelligence (AI) power solution development and delivery, many businesses need to build backend cloud capabilities. Well-poised organizations, marketing smart devices with AI and BlockChain capabilities prepare to refine compliance and regulatory capabilities in 2018. Volumes of health, financial, technical and privacy data, along with tightening compliance requirements by...
Predicting the future has never been more challenging - not because of the lack of data but because of the flood of ungoverned and risk laden information. Microsoft states that 2.5 exabytes of data are created every day. Expectations and reliance on data are being pushed to the limits, as demands around hybrid options continue to grow.
Digital Transformation and Disruption, Amazon Style - What You Can Learn. Chris Kocher is a co-founder of Grey Heron, a management and strategic marketing consulting firm. He has 25+ years in both strategic and hands-on operating experience helping executives and investors build revenues and shareholder value. He has consulted with over 130 companies on innovating with new business models, product strategies and monetization. Chris has held management positions at HP and Symantec in addition to ...
Enterprises have taken advantage of IoT to achieve important revenue and cost advantages. What is less apparent is how incumbent enterprises operating at scale have, following success with IoT, built analytic, operations management and software development capabilities - ranging from autonomous vehicles to manageable robotics installations. They have embraced these capabilities as if they were Silicon Valley startups.
As IoT continues to increase momentum, so does the associated risk. Secure Device Lifecycle Management (DLM) is ranked as one of the most important technology areas of IoT. Driving this trend is the realization that secure support for IoT devices provides companies the ability to deliver high-quality, reliable, secure offerings faster, create new revenue streams, and reduce support costs, all while building a competitive advantage in their markets. In this session, we will use customer use cases...